Evaluating the effectiveness of targeted therapies for thyroid carcinoma: an updated meta-analysis
Lists
Only you see this
Abstract
This meta-analysis revealed that the targeted drugs can significantly prolong PFS in patients with thyroid carcinoma, but the targeted drugs did not prolong the OS. Although the incidence of adverse reactions was significantly higher than that of the placebo group, the patients were still tolerable in drug group.
BibTeX
@article{lin2019evaluating,
author = {Shuai Lin and Jun Shen and Wanjun Zhao and Xiaofei Wang and Xiaoqing Wang and Jingqiang Zhu},
title = {{Evaluating the effectiveness of targeted therapies for thyroid carcinoma: an updated meta-analysis}},
journal = {Annals},
year = {2019},
doi = {10.21037/atm.2019.12.58},
}Loading related content...